Physician profile
William D Weiss
NPI 1124002662
$747.88
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $398 · 2020: $231 · 2021: $83.93 · 2022: $35.04.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $274.67 | 2019-2021 | |
| Si-Bone, INC. | $131.32 | 2019-2020 | |
| Radius Health, INC. | $79.47 | 2020-2022 | |
| Horizon Therapeutics Plc | $60.56 | 2019-2020 | |
| Smith+Nephew, INC. | $55.72 | 2019-2021 | |
| Zyla Life Sciences, INC. | $32.47 | 2019 | |
| Zimmer Biomet Holdings, INC. | $31.10 | 2019-2020 | |
| Bioventus LLC | $20.15 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $16.49 | 2021 | |
| Avanos Medical | $16.25 | 2019 | |
| Ethicon US, LLC | $15.80 | 2019 | |
| Kci USA, INC. | $13.88 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Weiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.